Brind.

Zimmer Biomet and Smith & Nephew were highlighted as strong medical products stocks on September 3, 2025.

1 report, 1 independent Updated Sep 3

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Zimmer Biomet Holdings Smith & Nephew (United States)

Keep exploring

The entities involved

Zimmer Biomet Holdings
medical device company

Nothing else this week.
Smith & Nephew (United States)
Nothing else this week.

Related events

Zimmer Biomet Holdings is leveraging clinical expertise to influence its product pipeline and challenge the core orthopedics and robotics market.Jun 7

Coverage

Newest first; wire copies grouped

Sep 3ZacksAre Investors Undervaluing Smith & Nephew SNATS (SNN) Right Now? Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find w